Cytokine & Growth Factor Reviews

Papers
(The TQCC of Cytokine & Growth Factor Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Editorial Board171
Potential effects of HMGB1 on viral replication and virus infection-induced inflammatory responses: A promising therapeutic target for virus infection-induced inflammatory diseases142
COVID-19: From emerging variants to vaccination129
Targeting the metabolism and immune system in pancreatic ductal adenocarcinoma: Insights and future directions126
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs112
Unveiling cytokine charge disparity as a potential mechanism for immune regulation109
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy96
Editorial Board91
Editorial Board86
Editorial Board81
Proteomics analysis of circulating small extracellular vesicles: Focus on the contribution of EVs to tumor metabolism77
CDK4/6 inhibition in hormone receptor-positive/HER2-negative breast cancer: Biological and clinical aspects71
Metabolic Regulation of cGAS-STING Signaling in the Tumor Microenvironment: Dual Immune Roles and Therapeutic Implications70
Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances67
Participation of interferons in psoriatic inflammation65
Cytokine symphony: Deciphering the tumor microenvironment and metastatic axis in oral cancer63
Molecular mechanisms of regulation of IL-1 and its receptors57
Immuno-metabolic control of the balance between Th17-polarized and regulatory T-cells during HIV infection56
Epithelial-to-mesenchymal transition transcription factors: New strategies for mesenchymal tissue regeneration55
Central role of Galectin-3 at the cross-roads of cardiac inflammation and fibrosis: Implications for heart failure and transplantation53
Novel insights into neuroinflammatory mechanisms in traumatic brain injury: Focus on pattern recognition receptors as therapeutic targets51
Exogenous drug-induced mouse models of atopic dermatitis51
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer50
TGF-β mediated drug resistance in solid cancer48
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review46
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles42
Immunosuppressive tumor microenvironment and uterine fibroids: Role in collagen synthesis41
Chemokines and chemokine receptors: Insights from human disease and experimental models of helminthiasis41
The cGAS-STING pathway: Post-translational modifications and functional implications in diseases39
Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-239
Multifaceted role of CD14 in innate immunity and tissue homeostasis37
MDSCs might be “Achilles heel” for eradicating CSCs36
Exosomes as a modulator of immune resistance in human cancers36
Exosomes: Another intercellular lipometabolic communication mediators in digestive system neoplasms?34
Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells34
COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling34
Editorial Board33
Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy32
The IFN-γ/miniTrpRS signaling axis: An insight into the pathophysiology of osteoporosis and therapeutic potential32
Quantitative and qualitative differences in the activation of a fibroblast growth factor receptor by different FGF ligands31
Decoding the roles of heat shock proteins in liver cancer31
Exploring inflammatory and fibrotic mechanisms driving diabetic nephropathy progression30
B cell-activating factor and its targeted therapy in autoimmune diseases29
The roles of cell-cell and organ-organ crosstalk in the type 2 diabetes mellitus associated inflammatory microenvironment29
Modulation of IL-33/ST2 signaling as a potential new therapeutic target for cardiovascular diseases29
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies28
Netrin-1: An emerging player in inflammatory diseases28
Nuclear translocation of RON receptor tyrosine kinase. New mechanistic and functional insights27
From senescence to scarring: Exploring TGF-β signaling in cellular aging, fibrotic remodeling, and pulmonary fibrosis26
Forgetting COVID-19 – Introduction to the special issue26
The impact of adipokines on vascular networks in adipose tissue26
Liquid biopsy analysis of lipometabolic exosomes in pancreatic cancer24
Extracellular vesicles: Emerging mediators of cell communication in gastrointestinal cancers exhibiting metabolic abnormalities23
Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation23
Therapeutic inhibition of the JAK-STAT pathway in the treatment of inflammatory bowel disease22
Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism22
mTOR in programmed cell death and its therapeutic implications22
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance22
Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy21
Editorial Board21
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression21
Glioblastoma-associated macrophages: A key target in overcoming glioblastoma therapeutic resistance21
Cholecystokinin and gastrin as immune modulating hormones: Implications and applications20
Nefarious NTRK oncogenic fusions in pediatric sarcomas: Too many to Trk20
ALCAM/CD166: A pleiotropic mediator of cell adhesion, stemness and cancer progression20
Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders20
0.034188985824585